These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Antipsychotic polypharmacy refers to the co-prescription of more than one antipsychotic drug
for an individual patient. Surveys of prescribing in psychiatric services internationally have …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Background Although clozapine is an effective option for treatment-resistant schizophrenia
(TRS), there are still 1/3 to 1/2 of TRS patients who do not respond to clozapine. The main …

Background: Treatment options for clozapine resistance are diverse whereas, in contrast,
the evidence for augmentation or combination strategies is sparse. Aims: We aimed to …

About 40%-70% of the patients with treatment-resistant schizophrenia have a poor response
to adequate treatment with clozapine. The impact of clozapine-resistant schizophrenia …

Objective: Inadequate response to clozapine poses a substantial problem in the
pharmacotherapy of refractory schizophrenia. This randomized, double-blind, placebo …

Depression is a condition in which an individual feels lethargic, irritable, and guilty, has
difficulty and trouble, no enjoyment in life, mood swings, sometimes suicidal ideation and …

Background: Clozapine (CLZ) is not effective in more than 50% of treatment-resistant
schizophrenic patients. In these cases, several pharmacological strategies are used in …

Nervous system toxicity with current antituberculosis pharmacotherapy is relatively
uncommon, although the frequency of the usage of antituberculosis therapy requires that …